KDM5B (Gene)

Synonyms:CT31, ENTREZ:10765, HGNC:18039, JARID1B, KDM5B, MIM:605393, MRT65, NM_001314042, NM_001347591, NM_006618, NP_001300971, NP_001334520, NP_006609, PLU-1, PLU1, PPP1R98, PUT1, RBBP2H1A, RBP2-H1, XM_011509090, XM_011509091, XM_011509092, XP_011507392, XP_011507393, XP_011507394, lysine demethylase 5B
Omim:OMIM:605393
Id:94860efc-0d9d-579f-ab9b-251afb27d6ac
Hgnc:HGNC:18039
Entrez:10765
Description:lysine demethylase 5B
This gene encodes a lysine-specific histone demethylase that belongs to the jumonji/ARID domain-containing family of histone demethylases. The encoded protein is capable of demethylating tri-, di- and monomethylated lysine 4 of histone H3. This protein plays a role in the transcriptional repression or certain tumor suppressor genes and is upregulated in certain cancer cells. This protein may also play a role in genome stability and DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View KDM5B's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with KDM5B.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using KDM5B.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for KDM5B.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KDM5B.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.